Surgery Websites
General Surgery »  Faculty »  Surgical Oncology »  Robert S. Warren, M.D.
Robert S. Warren, M.D.

Robert S. Warren, M.D.

Professor of Surgery
Division of General Surgery

Contact Information

1600 Divisadero Street
San Francisco, California 94143-1932
Academic Telephone: (415) 353-9294
Fax: (415) 353-9296
robert.warren@ucsf.edu
 
Open Popup
  • 1969-71, University of Minnesota B.A.,  Physiology, Magna Cum Laude
  • 1976-80, University of Minnesota Medical School, Minneapolis M.D.   
  • 1980-81, University of Minnesota, Intern, Surgery
  • 1981-88, University of Minnesota, Resident, Surgery
  • 1980-81, University of Minnesota, Postdoctoral Fellow, Surgery
  • 1981-88, University of Minnesota, Postdoctoral Fellow, Surgery
  • 1983-86, Memorial Sloan-Kettering Cancer Center, Fellow, Oncology Research
  • 1983-86, Memorial Sloan-Kettering Cancer Center, Postdoctoral Fellow, Oncology
  • American Board of Surgery, 1989
  • Surgical Oncology Program
  • Surgical Oncology Laboratory
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Department of Surgery

Robert S. Warren, M.D. is a Professor of Surgery and a specialist in gastrointestinal and liver cancer. He earned a medical degree at the University of Minnesota, where he completed a general surgery residency. After completing an oncology research fellowship at Memorial Sloan-Kettering Cancer Center in New York, he was an associate physician at Rockefeller University in New York. A board-certified surgeon, Dr. Warren joined UCSF Medical Center in 1988. Highly respected by his peers, Dr. Warren was named to the list of U.S. News "America's Top Doctors," a distinction reserved for the top 1% of physicians in the nation for a given specialty. His research focuses on the biology of colorectal cancer and how it spreads.

Dr. Warren is involved in clinical and laboratory research, which has centered on the biology of colorectal cancer metastasis that includes Vascular Endothelial Growth Factor (VEGF), Insulin-Like Growth Factors and Their Binding Proteins AS Modulators of Growth of Colorectal Cancer Metastases and Cytogenetics of Colorectal Cancer Metastasis. The laboratory work focuses on two areas: 1) autocrine growth factors and angiogenesis in colorectal cancer 2) molecular features which predict clinical outcome in primary and metastatic colorectal cancer.

  • Biology of colorectal cancer metastasis
  • Molecular features which predict clinical outcome in primary and metastatic colorectal cancer
  • Autocrine growth factors and angiogenesis in colorectal cancer
  • Vascular Endothelial Growth Factor (VEGF) Hypoxia and Colon Cancer
  • Insulin-Like Growth Factors and Their Binding Proteins As Modulators of Growth of Colorectal Cancer Metastases
  • Cytogenetics of Colorectal Cancer Metastasis
Data provided by UCSF Profiles, powered by CTSI
  • General Clinical Research Center
    Sponsor:
    Sponsor ID:
    Funding Period:
    Dec 1974
    -
    Mar 2009
    Co-Investigator
  • MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCER
    Sponsor:
    Sponsor ID:
    Funding Period:
    Mar 2000
    -
    Feb 2006
    Principal Investigator
  • ROLE OF CYTOKINES IN CANCER PATIENTS UNDERGOING SURGERY
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jul 1993
    -
    Jun 1999
    Principal Investigator
MOST RECENT PUBLICATIONS FROM A TOTAL OF 68
Data provided by UCSF Profiles, powered by CTSI
  1. Yu J, Navickas A, Asgharian H, Culbertson B, Fish L, Garcia K, Olegario JP, Dermit M, Dodel M, Hanisch B, Luo Y, Weinberg EM, Dienstmann R, Warren RS, Mardakheh FK, Goodarzi H. RBMS1 suppresses colon cancer metastasis through targeted stabilization of its mRNA regulon. Cancer Discov. 2020 Jun 08. View in PubMed
  2. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors. J Surg Oncol. 2020 Apr 14. View in PubMed
  3. Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2019 Dec 11. View in PubMed
  4. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. Prognostic impact of a large mesenteric mass >2?cm in ileal neuroendocrine tumors. J Surg Oncol. 2019 Dec; 120(8):1311-1317. View in PubMed
  5. Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, Moreno V, Warren RS, Lothe RA, Guinney J. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. Ann Oncol. 2019 10 01; 30(10):1622-1629. View in PubMed
  6. View All Publications

 

Site Directory
    X